News >

Pipeline Updates Advance Paradigms Across Lymphomas

Brandon Scalea
Published: Friday, May 31, 2019

Matthew S. McKinney, MD

Matthew S. McKinney, MD

Swapping bleomycin with brentuximab vedotin (Adcetris) has proved to be superior to the standard 4-drug chemotherapy regimen of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) in patients with Hodgkin lymphoma. However, the toxicity associated with the antibody-drug conjugate is a remaining challenge, as is choosing which patients should receive it, said Matthew S. McKinney, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication